vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)
Close on Nov 17, 2026Market cap $68.37MP/E –Yield –
vTv Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
vTv Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -12.9%. For fiscal 2024 it was -1815.3%, against -949.7% the year before. The highest annual figure on record is -63.6% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -1815.3% | −865.7 |
| FY2022 | Dec 31, 2022 | -949.7% | −625.4 |
| FY2021 | Dec 31, 2021 | -324.3% | −191.8 |
| FY2020 | Dec 31, 2020 | -132.5% | +339.4 |
| FY2019 | Dec 31, 2019 | -471.9% | −408.3 |
| FY2018 | Dec 31, 2018 | -63.6% | +5484.1 |
| FY2017 | Dec 31, 2017 | -5547.8% | −2968.6 |
| FY2016 | Dec 31, 2016 | -2579.2% | +2719.1 |
| FY2015 | Dec 31, 2015 | -5298.3% | −2967.7 |
| FY2014 | Dec 31, 2014 | -2330.6% | +2608.2 |
| FY2013 | Dec 31, 2013 | -4938.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | 65.5% | +35076.6 |
| Q4 FY2024 | Dec 31, 2024 | -21376.5% | −21026.1 |
| Q1 FY2024 | Mar 31, 2024 | -486.5% | +77857.9 |
| Q4 FY2022 | Dec 31, 2022 | -52722.2% | −52686.0 |
| Q2 FY2022 | Jun 30, 2022 | -35011.1% | −28255.6 |
| Q1 FY2022 | Mar 31, 2022 | -350.3% | +79.3 |
| Q4 FY2021 | Dec 31, 2021 | -78344.4% | −78362.0 |
| Q3 FY2021 | Sep 30, 2021 | -36.2% | +21863.8 |
| Q2 FY2021 | Jun 30, 2021 | -6755.6% | +52294.4 |
| Q1 FY2021 | Mar 31, 2021 | -429.7% | +62413.2 |
| Q4 FY2020 | Dec 31, 2020 | 17.6% | +45117.6 |
| Q3 FY2020 | Sep 30, 2020 | -21900.0% | −21742.3 |
| Q1 FY2020 | Mar 31, 2020 | -59050.0% | −58816.0 |
| Q4 FY2019 | Dec 31, 2019 | -62842.9% | −62818.7 |
| Q3 FY2019 | Sep 30, 2019 | -45100.0% | −45076.4 |
| Q2 FY2019 | Jun 30, 2019 | -157.7% | −33.4 |
| Q1 FY2019 | Mar 31, 2019 | -234.0% | −91.0 |
| Q4 FY2018 | Dec 31, 2018 | -24.1% | +1826.1 |
| Q3 FY2018 | Sep 30, 2018 | -23.6% | +24309.7 |
| Q2 FY2018 | Jun 30, 2018 | -124.2% | +30360.4 |
| Q1 FY2018 | Mar 31, 2018 | -143.0% | +13923.6 |
| Q4 FY2017 | Dec 31, 2017 | -1850.2% | +8807.7 |
| Q3 FY2017 | Sep 30, 2017 | -24333.3% | −13825.4 |
| Q2 FY2017 | Jun 30, 2017 | -30484.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -14066.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -10657.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -10507.9% | – |
See a number that looks wrong?